D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 22,038 247 World Ranking 13150 National Ranking 387

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

Haruhiko Yoshida mostly deals with Hepatocellular carcinoma, Internal medicine, Surgery, Gastroenterology and Radiology. The Hepatocellular carcinoma study combines topics in areas such as Hepatitis C virus, Hepatitis C, Catheter ablation, Carcinoma and Survival analysis. As part of one scientific family, Haruhiko Yoshida deals mainly with the area of Internal medicine, narrowing it down to issues related to the Pathology, and often Tumor marker.

His study looks at the relationship between Surgery and topics such as Radiofrequency ablation, which overlap with Survival rate. His Gastroenterology study combines topics from a wide range of disciplines, such as Hazard ratio, Immunology, Hepatitis and Risk factor. He has included themes like Cholecystitis, Pancreatic cancer and Magnetic resonance cholangiopancreatography in his Radiology study.

His most cited work include:

  • Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma (1047 citations)
  • Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan (963 citations)
  • Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. (790 citations)

What are the main themes of his work throughout his whole career to date?

Haruhiko Yoshida focuses on Internal medicine, Gastroenterology, Hepatocellular carcinoma, Surgery and Radiology. His biological study deals with issues like Hepatitis C virus, which deal with fields such as Viral load. The study incorporates disciplines such as Fibrosis, Cancer and Risk factor in addition to Gastroenterology.

In his research, Catheter ablation is intimately related to Radiofrequency ablation, which falls under the overarching field of Hepatocellular carcinoma. In the subject of general Radiology, his work in Stent is often linked to In patient, thereby combining diverse domains of study. His Cancer research research includes elements of Carcinogenesis and microRNA.

He most often published in these fields:

  • Internal medicine (56.64%)
  • Gastroenterology (40.92%)
  • Hepatocellular carcinoma (34.69%)

What were the highlights of his more recent work (between 2011-2020)?

  • Internal medicine (56.64%)
  • Gastroenterology (40.92%)
  • Hepatocellular carcinoma (34.69%)

In recent papers he was focusing on the following fields of study:

Haruhiko Yoshida mainly investigates Internal medicine, Gastroenterology, Hepatocellular carcinoma, Surgery and Radiology. As part of the same scientific family, he usually focuses on Internal medicine, concentrating on Hepatitis C virus and intersecting with Viral load. His research in Gastroenterology intersects with topics in Fibrosis, Diabetes mellitus, Immunology and Genotype.

His work carried out in the field of Hepatocellular carcinoma brings together such families of science as Survival rate, Percutaneous, Radiofrequency ablation and Carcinoma. In his study, which falls under the umbrella issue of Radiofrequency ablation, Survival analysis is strongly linked to Catheter ablation. His studies deal with areas such as Multivariate analysis, Adverse effect and Cohort as well as Surgery.

Between 2011 and 2020, his most popular works were:

  • Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma (1047 citations)
  • Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors (441 citations)
  • Loss of 5‐hydroxymethylcytosine is accompanied with malignant cellular transformation (206 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

His primary areas of investigation include Internal medicine, Hepatocellular carcinoma, Gastroenterology, Surgery and Radiofrequency ablation. His work on Hepatology, Fibrosis, Predictive value of tests and Pancreas as part of general Internal medicine study is frequently linked to Wave velocity, therefore connecting diverse disciplines of science. His work deals with themes such as Regulator, Carcinoma, Radiology and Key, which intersect with Hepatocellular carcinoma.

His Radiology study combines topics in areas such as Liver tumor, Complication and Colorectal surgery. His studies in Gastroenterology integrate themes in fields like Diabetes mellitus, Odds ratio, Oncology and Fatty liver. His study in Radiofrequency ablation is interdisciplinary in nature, drawing from both Adverse effect, Percutaneous, Liver transplantation and Catheter ablation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma

Kentaro Kojima;Akemi Takata;Charles Vadnais;Motoyuki Otsuka.
Nature Communications (2012)

1624 Citations

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

Haruhiko Yoshida;Yasushi Shiratori;Mitsuhiko Moriyama;Yasuyuki Arakawa.
Annals of Internal Medicine (1999)

1528 Citations

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Masao Omata;Laurentius A. Lesmana;Ryosuke Tateishi;Pei Jer Chen.
Hepatology International (2010)

1094 Citations

Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy

Yasushi Shiratori;Fumio Imazeki;Mitsuhiko Moriyama;Michitami Yano.
Annals of Internal Medicine (2000)

1025 Citations

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

Ryosuke Tateishi;Shuichiro Shiina;Takuma Teratani;Shuntaro Obi.
Cancer (2005)

964 Citations

A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma

Shuichiro Shiina;Takuma Teratani;Shuntaro Obi;Shinpei Sato.
Gastroenterology (2005)

958 Citations

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors

Shuichiro Shiina;Ryosuke Tateishi;Toru Arano;Koji Uchino.
The American Journal of Gastroenterology (2012)

602 Citations

Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography

Ryota Masuzaki;Ryosuke Tateishi;Haruhiko Yoshida;Eriko Goto.
Hepatology (2009)

437 Citations

Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.

Keiji Ogura;Shin Maeda;Masafumi Nakao;Takeshi Watanabe.
Journal of Experimental Medicine (2000)

408 Citations

Hepatocellular carcinoma with extrahepatic metastasis

Koji Uchino;Ryosuke Tateishi;Shuichiro Shiina;Miho Kanda.
Cancer (2011)

352 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Haruhiko Yoshida

Kazuhiko Koike

Kazuhiko Koike

University of Tokyo

Publications: 214

Masatoshi Kudo

Masatoshi Kudo

Kindai University

Publications: 138

Masao Omata

Masao Omata

University of Tokyo

Publications: 89

Osamu Yokosuka

Osamu Yokosuka

Chiba University

Publications: 72

Kazuaki Chayama

Kazuaki Chayama

Hiroshima University

Publications: 65

Hyo Keun Lim

Hyo Keun Lim

Samsung Medical Center

Publications: 64

Yoshio Yamaoka

Yoshio Yamaoka

Oita University

Publications: 63

Namiki Izumi

Namiki Izumi

Musashino Red Cross Hospital

Publications: 58

Norihiro Kokudo

Norihiro Kokudo

University of Tokyo

Publications: 58

Jeong Min Lee

Jeong Min Lee

Seoul National University Hospital

Publications: 57

Hiromitsu Kumada

Hiromitsu Kumada

Fukuoka University

Publications: 57

Richard M. Peek

Richard M. Peek

Vanderbilt University Medical Center

Publications: 53

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 45

Motoyuki Otsuka

Motoyuki Otsuka

University of Tokyo

Publications: 44

Takao Kawabe

Takao Kawabe

University of Tokyo

Publications: 43

Kenji Ikeda

Kenji Ikeda

University of California, San Francisco

Publications: 42

Trending Scientists

Herbert Bos

Herbert Bos

Vrije Universiteit Amsterdam

Xiangyu Wang

Xiangyu Wang

Curtin University

Matthew T. Currie

Matthew T. Currie

Morgan, Lewis & Bockius LLP

Patrick Bertrand

Patrick Bertrand

Université Catholique de Louvain

Hideo Ohno

Hideo Ohno

Tohoku University

Caterina Ducati

Caterina Ducati

University of Cambridge

Therese A. Markow

Therese A. Markow

University of California, San Diego

Lorenzo Ciannelli

Lorenzo Ciannelli

Oregon State University

Elva J. H. Robinson

Elva J. H. Robinson

University of York

Rodney L. Honeycutt

Rodney L. Honeycutt

Pepperdine University

Adam J. Engler

Adam J. Engler

University of California, San Diego

Pradeep K. Singh

Pradeep K. Singh

University of Washington

Eduard Roca

Eduard Roca

University of Barcelona

J. S. Holloway

J. S. Holloway

Earth System Research Laboratory

Denis J. Moss

Denis J. Moss

QIMR Berghofer Medical Research Institute

Jose Morais

Jose Morais

Université Libre de Bruxelles

Something went wrong. Please try again later.